Refine by
Detect Cancers Services
17 services found
by:Microvascular Therapeutics, LCC based inTucson, ARIZONA (USA)
Indication: Pancreatic Cancer. Detection of pancreatic cancers <1MM in size. ISSUED PATENT and ...
by:Biocollect based inZator, POLAND
We offer tools and devices for cervical cancer detection and diagnostic including a self-sampling device of our partner Oasis Diagnostics® Corporation for cervico-vaginal specimen for HPV test as well as for testing other viruses and bacteria from STI ...
Manufactured by:Aindra Systems based inBengaluru, INDIA
One woman dies every 2 minutes globally due to Cervical Cancer. Currently, there exists no reliable, smart and fast solution for the screening of Cervical Cancer in all developing nations. Although cervical cancer has a higher gestation period, due to lack of affordable and accessible screening tests, the count of women detected ...
by:Microvascular Therapeutics, LCC based inTucson, ARIZONA (USA)
Indication: Breast Cancer. Improved detection and differentiation on routine breast ultrasound, enabling faster, more accurate, and cheaper detection and treatment of breast cancer. ISSUED ...
Manufactured by:Grail, Inc. based inMenlo Park, CALIFORNIA (USA)
The STRIVE Study is a prospective, observational, longitudinal, cohort study that has enrolled approximately 100,000 women at the time of their screening mammogram. A subset of the data from STRIVE will be used to help validate GRAIL’s blood test for the early detection of multiple cancer types. Participants completed a health questionnaire and provided a ...
Manufactured by:Grail, Inc. based inMenlo Park, CALIFORNIA (USA)
Assessing the Implementation of an Investigational Multi-Cancer Early Detection Test into Clinical Practice. The PATHFINDER Study is a prospective, multi-center study that will evaluate the implementation of GRAIL’s multi-cancer early detection test into clinical practice. GRAIL’s test is designed to ...
Manufactured by:Self-screen B.V. based inAmsterdam, NETHERLANDS
Self-screen is constantly developing novel state-of-the-art clinical tests for (early) cancer detection. These tests meet growing requirements in both primary screening as well as triage settings. This could be in terms of terms of validation of certain sample types, such as existing cytology preservatives, or other media, or for instance new sample types such as ...
by:Vigilant Biosciences, Inc. based inAustin, TEXAS (USA)
This year alone, oral cancer, including oral cancer, will affect the lives of hundreds of thousands of individuals and their families. ...
Manufactured by:Grail, Inc. based inMenlo Park, CALIFORNIA (USA)
Evaluation of a New Blood Test for Detecting Multiple Types of Cancer Early. The SUMMIT Study is a prospective, observational, longitudinal, cohort study being conducted in London in the United Kingdom. It is designed to enroll approximately 25,000 men and women age 50 to 77 years who do not have a cancer diagnosis at the time of enrollment. ...
by:Greensboro Radiology based inGreensboro, NORTH CAROLINA (USA)
Mammograms are x-ray exams of the breast. They are most often used to screen for breast cancer in women who have no symptoms. Mammograms and other breast imaging tests can also be used in women who have breast symptoms, such as a lump or pain, or who have a suspicious change seen on a screening mammogram. Mammography is the only screening tool that has been demonstrated through ...
Manufactured by:Grail, Inc. based inMenlo Park, CALIFORNIA (USA)
Mapping the Landscape of Genomic Cancer Signals in the Blood. The Circulating Cell-free Genome Atlas (CCGA) Study is a prospective, observational, longitudinal, study designed to characterize the landscape of genomic cancer signals in the blood of people with and without cancer. The study has enrolled approximately 15,000 participants across 142 sites in the United States and Canada, and includes ...
Manufactured by:ITM Isotope Technologies Munich SE based inGarching / Munich, GERMANY
Targeted Radionuclide Therapy (TRT) or Peptide Receptor Radionuclide Therapy (PRRT) is a medical specialty using very small amounts of radioactive compounds, called radiopharmaceuticals, to diagnose and treat various diseases, like cancer. Once injected into the patient, the radiopharmaceutical finds its way to the tumor through the bloodstream and binds to the tumor specific receptor according ...
by:Oncimmune Holdings PLC based inNottingham, UNITED KINGDOM
EarlyCDT is a simple blood test that detects the elevated presence of autoantibodies generated by the body's immune system as a natural defence against cancer cells. EarlyCDT Lung is the world’s most thoroughly validated blood test for the detection of lung cancer and requires only a small volume of blood which can be taken ...
Manufactured by:Data Driven Diagnostic Sciences (D3Sciences) based inTucson, ARIZONA (USA)
Detecting, Diagnosing and Treating Cancer: To detect, diagnose, and treat internal cancer requires a team of healthcare providers led generally by three specialist physicians: oncologists, radiologists, and pathologists. Upon examining a patient, and assessing the indicators for the presence of the disease, the oncologist ...
by:Burning Rock Biotech Limited based inGuangzhou, CHINA
Cancer is a complicated disease caused by genetic variation. The genetic variation may deprive cells of the normal control function, leading to immortalization and cancer. And targeted drugs work well in cancer therapy, which can kill cancer cells that carry specific genes of variation. However, patients may differ from each other regarding the in vivo genetic variation. As a result, patients ...
Manufactured by:Soteria Medical BV based inArnhem, NETHERLANDS
Prostate cancer is the most common cancer, other than non-melanoma skin cancer, and the second leading cause of cancer-related death in men in the United States. Prostate cancer incidence rates rose dramatically in the late 1980s, when screening with the prostate-specific antigen (PSA) test, which received initial U.S. Food and Drug Administration approval in 1986, came into wide use. It is ...
by:2M Engineering Ltd. based inValkenswaard, NETHERLANDS
Driving Innovation Through our comprehensive product creation services; At 2M, we are experts in creating cutting-edge smart sensing solutions that propel innovation in various industries. Our services encompass a wide range of offerings, from providing one-time consultancy or development projects to delivering full end-to-end product creation ...